BETH ISRAEL DEACONESS MEDICAL CENTER — History
CCN 220086 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$1.7B
Latest Revenue (FY2022)
+11.0%
Revenue CAGR (3yr)
-38.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.4B | $1.9B | $1.7B | -11.4% | +11.0% |
| Operating Expenses | $2.0B | $2.1B | $2.3B | +9.5% | +8.3% |
| Operating Margin | -45.8% | -12.3% | -38.9% | -215.5% | +0.0% |
| Net Income | $-623M | $-233M | $-651M | -179.4% | +0.0% |
| Licensed Beds | 694 | 718 | 705 | -1.8% | +0.8% |
| Total Patient Days | 213,875 | 232,912 | 235,730 | +1.2% | +5.0% |
| Medicare Day % | 31% | 32% | 31% | -4.1% | -0.9% |
| Medicaid Day % | 20% | 19% | 9% | -55.6% | -34.6% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.1% ($1.4B → $1.7B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.0%
This Hospital
+7.6%
State Avg
Latest Margin
-38.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.8B | -35.5% |
| FY2024 (proj) | $2.0B | -32.0% |
| FY2025 (proj) | $2.1B | -28.6% |